628 related articles for article (PubMed ID: 22108246)
1. ICRP Publication 115. Lung cancer risk from radon and progeny and statement on radon.
Tirmarche M; Harrison JD; Laurier D; Paquet F; Blanchardon E; Marsh JW;
Ann ICRP; 2010 Feb; 40(1):1-64. PubMed ID: 22108246
[TBL] [Abstract][Full Text] [Related]
2. Estimating lung cancer mortality from residential radon using data for low exposures of miners.
Lubin JH; Tomásek L; Edling C; Hornung RW; Howe G; Kunz E; Kusiak RA; Morrison HI; Radford EP; Samet JM; Tirmarche M; Woodward A; Yao SX
Radiat Res; 1997 Feb; 147(2):126-34. PubMed ID: 9008203
[TBL] [Abstract][Full Text] [Related]
3. Dose conversion factors for radon: recent developments.
Marsh JW; Harrison JD; Laurier D; Blanchardon E; Paquet F; Tirmarche M
Health Phys; 2010 Oct; 99(4):511-6. PubMed ID: 20838092
[TBL] [Abstract][Full Text] [Related]
4. Inhalation dose assessment of indoor radon progeny using biokinetic and dosimetric modeling and its application to Jordanian population.
Al-Jundi J; Li WB; Abusini M; Tschiersch J; Hoeschen C; Oeh U
J Environ Radioact; 2011 Jun; 102(6):574-80. PubMed ID: 21477902
[TBL] [Abstract][Full Text] [Related]
5. Management of radon: a review of ICRP recommendations.
Vaillant L; Bataille C
J Radiol Prot; 2012 Sep; 32(3):R1-12. PubMed ID: 22809956
[TBL] [Abstract][Full Text] [Related]
6. Radon exposure assessment and dosimetry applied to epidemiology and risk estimation.
Puskin JS; James AC
Radiat Res; 2006 Jul; 166(1 Pt 2):193-208. PubMed ID: 16808608
[TBL] [Abstract][Full Text] [Related]
7. Radon-progeny exposure and lung cancer risk in a cohort of Newfoundland fluorspar miners.
Morrison HI; Villeneuve PJ; Lubin JH; Schaubel DE
Radiat Res; 1998 Jul; 150(1):58-65. PubMed ID: 9650603
[TBL] [Abstract][Full Text] [Related]
8. Risk of lung cancer from radon exposure: contribution of recently published studies of uranium miners.
Tirmarche M; Harrison J; Laurier D; Blanchardon E; Paquet F; Marsh J
Ann ICRP; 2012; 41(3-4):368-77. PubMed ID: 23089036
[TBL] [Abstract][Full Text] [Related]
9. Biokinetic and dosimetric modelling in the estimation of radiation risks from internal emitters.
Harrison J
J Radiol Prot; 2009 Jun; 29(2A):A81-A105. PubMed ID: 19454809
[TBL] [Abstract][Full Text] [Related]
10. Mortality risk in the French cohort of uranium miners: extended follow-up 1946-1999.
Vacquier B; Caer S; Rogel A; Feurprier M; Tirmarche M; Luccioni C; Quesne B; Acker A; Laurier D
Occup Environ Med; 2008 Sep; 65(9):597-604. PubMed ID: 18096654
[TBL] [Abstract][Full Text] [Related]
11. A combined analysis of North American case-control studies of residential radon and lung cancer.
Krewski D; Lubin JH; Zielinski JM; Alavanja M; Catalan VS; Field RW; Klotz JB; Létourneau EG; Lynch CF; Lyon JL; Sandler DP; Schoenberg JB; Steck DJ; Stolwijk JA; Weinberg C; Wilcox HB
J Toxicol Environ Health A; 2006 Apr; 69(7):533-97. PubMed ID: 16608828
[TBL] [Abstract][Full Text] [Related]
12. Comparisons of lung tumour mortality risk in the Japanese A-bomb survivors and in the Colorado Plateau uranium miners: support for the ICRP lung model.
Little MP
Int J Radiat Biol; 2002 Mar; 78(3):145-63. PubMed ID: 11869470
[TBL] [Abstract][Full Text] [Related]
13. Cigarette use and the estimation of lung cancer attributable to radon in the United States.
Lubin JH; Steindorf K
Radiat Res; 1995 Jan; 141(1):79-85. PubMed ID: 7997518
[TBL] [Abstract][Full Text] [Related]
14. Joint analysis of three European nested case-control studies of lung cancer among radon exposed miners: exposure restricted to below 300 WLM.
Hunter N; Muirhead CR; Tomasek L; Kreuzer M; Laurier D; Leuraud K; Schnelzer M; Grosche B; Placek V; Heribanova A; Timarche M
Health Phys; 2013 Mar; 104(3):282-92. PubMed ID: 23361424
[TBL] [Abstract][Full Text] [Related]
15. Lung cancer risk and radon exposure in a cohort of iron ore miners in Malmberget, Sweden.
Jonsson H; Bergdahl IA; Akerblom G; Eriksson K; Andersson K; Kågström L; Järvholm B; Damber L
Occup Environ Med; 2010 Aug; 67(8):519-25. PubMed ID: 20647379
[TBL] [Abstract][Full Text] [Related]
16. Population attributable fraction for lung cancer due to residential radon in Switzerland and Germany.
Menzler S; Piller G; Gruson M; Rosario AS; Wichmann HE; Kreienbrock L
Health Phys; 2008 Aug; 95(2):179-89. PubMed ID: 18617799
[TBL] [Abstract][Full Text] [Related]
17. Lung cancer risk and effective dose coefficients for radon: UNSCEAR review and ICRP conclusions.
Harrison JD
J Radiol Prot; 2021 Jun; 41(2):. PubMed ID: 33823504
[TBL] [Abstract][Full Text] [Related]
18. The conversion of exposures due to radon into the effective dose: the epidemiological approach.
Beck TR
Radiat Environ Biophys; 2017 Nov; 56(4):353-364. PubMed ID: 28916937
[TBL] [Abstract][Full Text] [Related]
19. Accounting for smoking in the radon-related lung cancer risk among German uranium miners: results of a nested case-control study.
Schnelzer M; Hammer GP; Kreuzer M; Tschense A; Grosche B
Health Phys; 2010 Jan; 98(1):20-8. PubMed ID: 19959947
[TBL] [Abstract][Full Text] [Related]
20. An overview of the North American residential radon and lung cancer case-control studies.
Field RW; Krewski D; Lubin JH; Zielinski JM; Alavanja M; Catalan VS; Klotz JB; Létourneau EG; Lynch CF; Lyon JL; Sandler DP; Schoenberg JB; Steck DJ; Stolwijk JA; Weinberg C; Wilcox HB
J Toxicol Environ Health A; 2006 Apr; 69(7):599-631. PubMed ID: 16608829
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
